Ulcerative Colitis

Featured Article
New research has found a novel plasmid associated with ulcerative colitis, but it is unclear if the molecule is a marker of the disease.
Patients with ulcerative colitis in remission may be more likely to experience moderate to severe levels of fatigue and lack of productivity under certain conditions.
Earlier this year, the American Gastroenterological Association released a clinical guideline on managing moderate to severe ulcerative colitis (UC). Do you know what the guideline suggests for treatment of UC? Take our quiz to show your knowledge!
Researchers also found that patients with ulcerative colitis who had taken biologic drugs showed no greater rates of complications after colectomy than patients who had not taken these agents.
The precise mechanisms by which diet contributes to flares of ulcerative colitis or even development of the disease is not clear, but most patients look to their gastroenterologists for nutritional advice. Tell us what advice you give on diet in the management of ulcerative colitis.
The American College of Gastroenterology clinical guideline for ulcerative colitis (UC) advises looking beyond C-reactive protein to assess active inflammation. Do you know the other markers the ACG recommends be checked? Take our quiz to find out!
An award-winning poster from the American College of Gastroenterology 2020 clinical meeting examined the outcomes of children who have ileal-pouch anal-anastomosis surgery for treatment of ulcerative colitis.
An observational study looked at the safety and efficacy of the anti-integrin vedolizumab vs anti-tumor necrosis factor therapies in treating patients with ulcerative colitis.
Earlier this year, the American Gastroenterological Association issued clinical practice guidelines on managing moderate to severe ulcerative colitis. Do you know what the guidelines recommend regarding combination vs monotherapy? Take our quick quiz to find out!
Researchers assessed the efficacy of tofacitinib in patients with moderate to severe ulcerative colitis after 36 months of treatment. The results were encouraging.
A 60-year-old man presented to the emergency department with abdominal pain, mild rectal bleeding, tenesmus, and frequent liquid mucous stools for 18 days, reporting “loose stools” in the morning and several “explosive, watery stools” in the afternoon.